openPR Logo
Press release

Mitochondrial Myopathy Diagnosis & Treatment Market Development, market Trend, Segmentation and Forecast to 2020.

08-10-2017 02:11 PM CET | Health & Medicine

Press release from: Market Research Future

Market Highlights
Mitochondrial myopathies are diseases of genetic nature associated with mitochondrial diseases caused by certain nuclear DNA deletions. Mitochondrial myopathies affect mitochondria which is responsible for energy production within a cell associated with mitochondrial disease. Thus, they cause low energy and free radical production which results in a variety of symptoms.

As there is no cure for mitochondrial myopathies, the treatment involves only symptomatic treatment to manage the symptoms and to slow the progression of the disease. The symptomatic treatment includes vitamin therapy, adequate nutrition etc. The mitochondrial myopathies supplement cocktail consist of mixtures of coenzyme Q-10, L-Carnitine, B-Vitamins, Thiamine (B1), Riboflavin (B2), antioxidants such as Vitamin C and Vitamin E etc. Many of these supplements are needed for several key enzymatic steps in the production of energy by mitochondria. For example, Thiamine is a cofactor for pyruvate dehydrogenase complex which improves lactate and pyruvate levels. Vitamins such as B complex include: B3, B6, B12 and folic acid (B9). Folic acid prevents the development of anaemia and helps in the development of healthy new cells.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/3950

Key Findings:
• Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) and Progressive External Ophthalmoplegia (PEO) are the most commonly found conditions in patients with mitochondrial myopathy. The global MELAS diagnosis & treatment market is expected to grow at the CAGR of 19.39% during 2021 to 2025.
• Genetic tests accounted for the largest market share in 2016, and is projected to grow at a CAGR of 10.11% during 2017 to 2020.
• Supportive therapy captured the whole market share in 2016, and is projected to grow at a CAGR of 9.82% during 2017 to 2020.

Key players of Global Mitochondrial myopathy diagnosis & treatment Market:
• Centogene AG,
• GeneDx,
• Ixchel Pharma,
• Khondrion BV,
• Mitobridge,
• NeuroVive Pharmaceutical AB,
• Reata Pharmaceuticals Inc.,
• Stealth Biotherapeutics
• others.

The genetic testing segment is expected to yield high growth with reference to diagnostics for mitochondrial myopathies. Next Generation Sequencing (NGS) is extremely fast as compared to Sanger sequencing and has mostly superseded conventional Sanger sequencing in genome research, and is expected to do so also in the clinical practice. NGS has an advantage such as greater speed, cost, and accuracy which is expected to become the de facto standard for tests for mitochondrial disorders.
Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Mitochondrial Myopathy Diagnosis & Treatment Market Research Report- Global Forecast till 2020”

Segmentation:
The global mitochondrial myopathy diagnosis & treatment market is segmented on the basis of type, diagnostic tests and therapy.
Segmentation Based on type, the market has been segmented as mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), progressive external ophthalmoplegia (PEO), myoclonic epilepsy with ragged red fibres (MERRF), mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE), Kearns–Sayre syndrome (KSS), mitochondrial DNA depletion syndrome (MDS), Pearson syndrome, Leigh syndrome, neuropathy, ataxia, and retinitis pigmentosa (NARP).
Segmentation Based on the diagnostic tests, the market has been segmented as genetic tests, muscle biopsy and biochemical test.
Segmentation Based on the therapy, the market has been segmented as supportive therapy and targeted therapy.

Browse full report @ https://www.marketresearchfuture.com/reports/mitochondrial-myopathy-diagnosis-treatment-market-3950

Table of Content

1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.4.1 Assumptions
1.4.2 Limitations
1.5 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Introduction
3.2 Drivers
3.2.1 Rise in number of mitochondrial myopathy incidence rate and growing number of screening services.
3.2.2 Government funding and incentives for rare genetic diseases
3.3 Restraints
3.3.1 Poor treatment options and absence of curative treatment
3.3.2 Lack of awareness and diagnosis of the rare mitochondrial disorders
3.4 Opportunities
3.4.1 Faster market uptake and low marketing cost
3.4.2 Research and development
3.5 Challenges
3.5.1 Rare nature of the disease
3.5.2 Poor understanding of mitochondria and genetics
3.5.3 Cost of drug development and high investment risk
4 Market Factor Analysis
4.1 Porter’s Five Forces Analysis
4.1.1 Threat from a New Entrant
4.1.2 Bargaining Power of Buyer
4.1.3 Bargaining Power of Supplier
4.1.4 Threat from substitute
4.1.5 Intensity of Competitive Rivalry
4.2 Pipeline Analysis
4.2.1 Introduction
4.2.2 KH176
4.2.3 Elamipretide
4.2.4 RTA 408
4.2.5 IXC 103
4.2.6 NV556
4.3 Mega Trends
4.3.1 Strategies for increasing mitochondrial biogenesis
4.3.2 Antioxidant approaches
4.3.3 Targeting mitochondrial dynamics and biogenesis
4.3.4 Mitochondrial membrane lipids as therapeutic targets
4.3.5 Nucleoside replacement and gene therapy
4.3.6 Enzyme replacement therapy
4.4 Investment Opportunity Analysis
4.4.1 Market size (current and future), growth rate, and profitability
4.4.2 Investment Risks
4.4.3 Market Outlook
4.4.4 Competitors
4.4.5 Projections
5 Global Mitochondrial Myopathy Diagnosis & Treatment Market, By Type
5.1 Introduction
5.2 Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)
5.3 Progressive External Ophthalmoplegia (PEO)
5.4 Myoclonic Epilepsy with Ragged Red Fibres (MERRF)
5.5 Mitochondrial Neurogastrointestinal Encephalopathy Syndrome (MNGIE)
5.6 Kearns–Sayre Syndrome (KSS)
5.7 Mitochondrial DNA Depletion Syndrome (MDS)
5.8 Pearson Syndrome
5.9 Leigh Syndrome
5.10 Neuropathy, Ataxia, and Retinitis Pigmentosa (NARP)
6 Global Mitochondrial Myopathy Diagnosis & Treatment Market, By Diagnostic Test
Continue…………

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mitochondrial Myopathy Diagnosis & Treatment Market Development, market Trend, Segmentation and Forecast to 2020. here

News-ID: 664516 • Views:

More Releases from Market Research Future

US Color Cosmetics Market Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trend …
Color cosmetics have long been an integral part of American culture, offering a wide range of products to enhance beauty and express individuality. The US color cosmetics market is a dynamic and vibrant landscape, driven by evolving consumer preferences, innovative product offerings, and changing beauty trends. In this article, we explore the key drivers, trends, restraints, and opportunities shaping the US color cosmetics market. The US Color Cosmetics Market was valued
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Trends by 2032
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Tr …
Takeout containers have become an integral part of the modern dining experience, offering convenience and portability for consumers on-the-go. In the United States, the takeout containers market has witnessed significant growth in recent years, driven by changing consumer lifestyles, the rise of food delivery services, and increasing environmental concerns. This article explores the key trends, drivers, restraints, and opportunities shaping the US takeout containers market. US Takeout Containers Market size was
Construction IoT Market Size with Growth Opportunities, Top Countries Data, Future Trends and Share with Revenue Forecast 2024 to 2032
Construction IoT Market Size with Growth Opportunities, Top Countries Data, Futu …
The Construction Internet of Things (IoT) market is rapidly expanding, revolutionizing the construction industry by enhancing productivity, safety, and efficiency. IoT in construction involves the use of sensors, devices, and software to collect and analyze data in real-time, enabling better decision-making and optimization of construction processes. The Construction IoT Market is estimated at US$ 51.78 billion in 2032 and is forecasted to increase rapidly at a CAGR of 16.8% from 2024
Logistics & Supply Chain Market By Business Top Key Players, Growth, Trend, Segmentation, Revenue and Industry Expansion Forecast Report
Logistics & Supply Chain Market By Business Top Key Players, Growth, Trend, Segm …
The logistics and supply chain market is a critical backbone of global commerce, ensuring the seamless flow of goods from production to consumption. It encompasses a vast network of processes, technologies, and providers working together to deliver products to customers efficiently and cost-effectively. Logistics & Supply Chain Market was valued at USD 9.1 Billion in 2024 and is expected to reach USD 14.72 Billion by 2032, registering a CAGR of 6.20%

All 5 Releases


More Releases for Mitochondrial

Full-Scale Mitochondrial Bioenergetics Services at Creative Biogene
As one of the leading bio-companies engaged in mitochondrial research, Creative Biogene, together with its large team of experts, creates a powerful mitochondrial research service platform. To satisfy the research needs of global customers on mitochondrial bioenergies, Creative Biogene provides partners with a comprehensive range of mitochondrial bioenergetics detection and analysis services based on years of experience and high-end instruments. Mitochondria are the primary source of ATP for most cells
Global Mitochondrial Myopathy Diagnosis & Treatment Market Analysis & Forecast 2 …
Mitochondrial Myopathy Diagnosis & Treatment Market 2020 comprises a detailed survey of the Mitochondrial Myopathy Diagnosis & Treatment Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025. Global "Mitochondrial Myopathy Diagnosis & Treatment" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Mitochondrial Myopathy Diagnosis & Treatment market
Mitochondrial Disorders Treatment Market: Market Dynamics
Increasing prevalence of mitochondrial disorders causing significant morbidity and mortality combined with the higher potential of genetic transmission to the next generation are the factors driving the market growth. According to the Wellcome Center for Mitochondrial Research, 2015, about 10 people per 100,000 have a mitochondrial disorders, which often express first in early childhood. According to the Genetic and Rare Disease Information Center, women with mitochondrial genetic disorders have 50%
Mitochondrial Myopathy Pharmaceutical and Healthcare Analysis Information
Mitochondrial Myopathies are the diseases that affect a specific part of the cells in the body. Specifically, mitochondrial diseases affect the mitochondria, which is the tiny energy factories found inside almost all our cells. The symptoms of Mitochondrial Myopathies are breathing issues, heart related issues, kidney problems, gastrointestinal problems or diabetes. It is a rare mutational disease and at present there is no concrete treatment available in the market for
Mitochondrial Myopathy Diagnosis & Treatment Market – Identify Opportunities a …
Mitochondrial myopathies are related to mitochondrial illnesses which can be due to nice nuclear DNA deletions and mutations. Mitochondrial myopathies affect mitochondria that is chargeable for power production within a cellular related to mitochondrial sickness. As a result, they reason low electricity and unfastened radical manufacturing which ends up in a spread of signs and symptoms and signs. The Global Mitochondrial Myopathy Diagnosis & Treatment Market is expected to reach $
Mitochondrial Myopathy Diagnosis & Treatment Market 2020: Comprehensive Research …
The global MELAS diagnosis & treatment market is expected to grow at the CAGR of 19.39% during 2021 to 2025.Genetic tests accounted for the largest market share in 2016, and is projected to grow at a CAGR of 10.11% during 2017 to 2020.Supportive therapy captured the whole market share in 2016, and is projected to grow at a CAGR of 9.82% during 2017 to 2020. Market Synopsis of Global Mitochondrial myopathy